Concepedia

Horst Schran

HS

Statistics

Publications

46

Citations

2.7K

H-Index

28

Active since

1979

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Tris Pharma (United States)

Novartis (France)

Horst Schran is an author at Novartis (United States) specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

1979–2015

46

Publications

46

Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases

Tianling Chen, James R. Berenson, Robert Vescio et al. · The Journal of Clinical Pharmacology · 2002 · 372 citations

, , +13

86Y-DOTA0-d-Phe1-Tyr3-octreotide (SMT487)—a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

François Jamar, Raffaella Barone, Isabelle Mathieu et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 240 citations

, , +8

Clinical Pharmacokinetics of the BCR–ABL Tyrosine Kinase Inhibitor Nilotinib

Chiaki Tanaka, Ophelia Yin, Venkat Sethuraman et al. · Clinical Pharmacology & Therapeutics · 2009 · 181 citations

, , +13

The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function

Andrej Skerjanec, James R. Berenson, Chyi-Hung Hsu et al. · The Journal of Clinical Pharmacology · 2003 · 159 citations

, , +15

Biodistribution and Plasma Protein Binding of Zoledronic Acid

H. Weiss, Ulrike Pfaar, Alain Schweitzer et al. · Drug Metabolism and Disposition · 2008 · 158 citations

, , +15

1–5 of 46